Patients without colonoscopic follow-up after abnormal fecal immunochemical tests are often unaware of the abnormal result and report several barriers to colonoscopy

BACKGROUND: The fecal immunochemical test (FIT) is the second most commonly used colorectal cancer (CRC) screening modality in the United States; yet, follow-up of abnormal FIT results with diagnostic colonoscopy is underutilized. Our objective was to determine patient-reported barriers to diagnosti...

Descripción completa

Detalles Bibliográficos
Autores principales: Cusumano, Vivy T., Corona, Edgar, Partida, Diana, Yang, Liu, Yu, Christine, May, Folasade P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168865/
https://www.ncbi.nlm.nih.gov/pubmed/32306919
http://dx.doi.org/10.1186/s12876-020-01262-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7168865/
https://www.ncbi.nlm.nih.gov/pubmed/32306919
http://dx.doi.org/10.1186/s12876-020-01262-7

Ejemplares similares